NOMAD POWER SOLUTIONS, INC. Liabilities Assumed
NOMAD POWER SOLUTIONS, INC. (NMAD) reported Liabilities Assumed of $16.38 thousand for the 9-month period ending 2021-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:LiabilitiesAssumed1 · last filed 2022-11-08
- NOMAD POWER SOLUTIONS, INC. liabilities assumed for the quarter ending 2020-12-31 was -$33.54K.
- NOMAD POWER SOLUTIONS, INC. liabilities assumed for fiscal 2020 was $10.47K.
| Period end | Liabilities Assumed 3 month | Liabilities Assumed 9 month | Liabilities Assumed 12 month |
|---|---|---|---|
| 2021-09-30 | $16.38K 10-Q · filed 2022-11-08 | ||
| 2020-12-31 | -$33.54K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-21 | $10.47K 10-K · filed 2022-03-21 | |
| 2020-09-30 | $44.01K 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |
| Serina Therapeutics, Inc. (SER) | United States | $0.054B | -2.35 |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B |